Wellards Academy
Dedicated e-learning for the pharma and medtech industries
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
From Genetic Puzzles to Precision Therapeutics
Press Releases | December 23, 2025 | Medscape Education
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...
Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series
Press Releases | December 23, 2025 | Medscape Education
Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...
What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?
Press Releases | December 23, 2025 | Medscape Education
Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...
Pharma’s digital dilemma: Finding the balance between speed, scale, and experience
Videos and Podcasts | December 19, 2025 | Graphite Digital
What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der Heiden (AstraZeneca) argued it starts with design systems. This quick...
Redefining digital ROI: Engagement, experience, and the new metrics of success
Videos and Podcasts | December 18, 2025 | Graphite Digital
Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and...
What will healthcare communications look like in 2026? Amiculum’s prediction of upcoming trends
White Papers and Resources | December 16, 2025 | Amiculum
By Sarah Theobald
Clinical research in 2026: The trends shaping tomorrow
White Papers and Resources | December 16, 2025 | Cuttsy + Cuttsy
Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.
Lack of education causes patients to stop vital treatments, survey finds
Press Releases | December 15, 2025 | Healthinote (by Cognitant)
Over three quarters of healthcare professionals call for co-created patient materials to drive engagement and trust, ultimately helping more patients benefit from prescribed treatments. Nearly 80% of healthcare professionals identify...
Tim Wright Updates ISPOR Europe MFN Pricing Presentation in New Interview
Press Releases | December 11, 2025 | Genesis Research Group
At ISPOR Europe in Glasgow, there were literal queues around the block for Tim Wright's HEOR Theater presentation 'MFN Pricing: More Fun to Navigate – A European Roadmap to Success,' with potentially...
A decade-long fight against a brain-eating amoeba
Videos and Podcasts | December 11, 2025 | Springer Nature
Our Nature Custom Media team recently took on an ambitious project: producing a video that spanned two continents, covered a decade of medical progress, and navigated regulatory hurdles.